JI

JIN YANG PHARMACEUTICAL. CO., LTD

Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.

007370 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 231, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

JIN YANG PHARMACEUTICAL. CO., LTD, established in 1971, is a pharmaceutical company dedicated to the research, development, and manufacturing of medicines. The company focuses on high-tech drug development to address a variety of diseases. Its research initiatives include the development of anti-cancer treatments, new drugs for leukemia based on molecular biology, and therapies derived from herbal preparations. JIN YANG PHARMACEUTICAL also engages in joint research, such as developing specialized nutritional foods for obesity treatment. The company's product portfolio covers a range of therapeutic areas, including treatments for the digestive and respiratory systems, anti-diabetics, antivirals, and antihistamines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 48.0 KB
2025-09-17 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 46.2 KB
2025-08-18 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 12.1 KB
2025-08-18 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-07-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.3 KB
2025-07-08 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.3 KB
2025-07-08 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 30.6 KB
2025-07-08 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 25.2 KB
2025-07-08 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 31.3 KB
2025-07-03 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 30.2 KB
2025-07-03 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 18.7 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB

Automate Your Workflow. Get a real-time feed of all JIN YANG PHARMACEUTICAL. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for JIN YANG PHARMACEUTICAL. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.